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Introduction

Case report

The advent of leadless pacemakers facilitated right ventricular pacing while avoiding short-term risks of pneumothorax
and surgical site infection and long-term risk of vascular stenosis.1 Until recently, the only available pacing mode on a
leadless pacemaker was VVI, which limited its usage to
patients with permanent atrial ﬁbrillation with bradycardia,
patients requiring only intermittent backup ventricular pacing, and patients with vascular access issues that prohibit
traditional pacemaker implantation. The Micra AV (Medtronic PLC, Dublin, Ireland) leadless cardiac pacemaker
was recently FDA approved and allows for atrial sensed–
ventricular paced applications, which have broadened potential usage to include patients in sinus rhythm with symptomatic second- and third-degree heart block.2 The Micra
leadless pacemaker is delivered via a 23F deﬂectable sheath
inserted typically from the right groin. The device is attached
to the myocardium by nitinol tines and is typically placed in a
location on the right ventricular septum or apex. In a recently
published series of long-term follow-up of Micra pacemakers, the rate of major complications was 1.51% and 1 device dislodgement without embolization was reported.3 We
hereby describe a novel technique for retrieval of a dislodged
Micra AV device, which occurred in the ﬁrst pediatric patient
implanted with such a device, at the time of publication
(Medtronic Inc, personal communication).

A 15-year-old male patient with a history of congenital second- and third-degree heart block underwent dual-chamber
pacemaker placement in 2017 from a left axillary vein
approach at the age of 13. Although the procedure was uncomplicated, he developed a left-sided surgical site infection
9 months later that grew Staphylococcus hominis, Staphylococcus epidermidis, and Micrococcus luteus. He underwent
left-sided device and lead extraction and completed a prolonged course of intravenous antibiotic therapy before undergoing a right-sided dual-chamber pacemaker implantation in
September 2018. Given his history of surgical site infection,
this pacemaker was implanted with an antimicrobial pouch
(TYRX Absorbable Antibacterial Envelope; Medtronic
PLC, Dublin, Ireland), and parenteral antibiotics were given
both pre and post device placement and oral doxycycline was
given for 6 months post implantation. Although this procedure was uncomplicated, he developed another surgical site
infection in January 2020 and underwent device and lead
extraction. Both wound and blood cultures were positive
for Streptococcus pyogenes. The patient received a prolonged course of antibiotic therapy with vancomycin initially
and then ceftriaxone. During his 3-week course of antibiotic
therapy, he continued to have intermittent symptomatic second- and third-degree heart block but did not require temporary transvenous pacing. His previously implanted
pacemaker had a 91.2% ventricular pacing rate (in AS-VP
mode), which conﬁrmed that he would likely need his pacemaker replaced. Given his history of recurrent device infections occurring at times remote from initial implantation
and despite extensive measures to prevent infection, various
treatment options were considered, including submuscular
implant. The Micra AV leadless pacemaker had recently
been approved and became commercially available the
week that device reimplantation was being considered.
Although leadless pacing is traditionally not considered in
patients this young, given his history of recurrent device infections despite extensive anti-infective measures, it was
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KEY TEACHING POINTS
 Recurrent surgical site infections separated in time
from the original implant suggest alternate
methods of pacing should be considered.
 Use of a large-bore, long sheath to retrieve an
embolized device in the pulmonary artery provides
proximity and support as well as allows safe passage
through the heart without injuring adjacent
structures.
 Use of a 2-snare technique at the distal and
proximal ends of an embolized leadless pacemaker
facilitates retraction of the tines and distal control
of the device while the proximal snare is used to
retract the device.

felt that the Micra AV leadless pacemaker was the best option
for him.
The patient underwent placement of a Micra AV pacemaker via transcatheter placement from the right groin. After
contrast injection was performed through the catheter to visualize the right ventricle, a location was chosen on the distal
right ventricular septum. The pull and hold test conﬁrmed
that 3 out of the 4 tines were fully attached to the ventricular
myocardium. The engagement of the 3 tines was conﬁrmed
with 2 cardiac electrophysiologists, 1 of whom had extensive
experience with leadless pacemaker implantation. The device
had sensed R waves of 13.5 mV, a pacing impedance of 500
ohms and pacing threshold of 0.5 V @ 0.24 ms. The
following day, the device check revealed that the sensing
had decreased to 10.0 mV, the impedance was stable at 500
ohms, and the pacing threshold increased to 3.75 V at 1.0
ms. A chest radiograph as well as echocardiogram both
conﬁrmed that the leadless pacemaker was attached to the
ventricular septum but its position had shifted slightly from
the original implant position.
Subsequently, the patient returned to the electrophysiology laboratory for planned repeat Micra AV device placement and retrieval of the original Micra AV via snare.
Immediately prior to the procedure, the device was interrogated and there was lack of capture of ventricular myocardium at any output. Fluoroscopy conﬁrmed that the
original Micra AV had migrated to the left pulmonary artery.
A second Micra AV was placed on the mid-ventricular
septum following a contrast injection. Once again, a pull
and hold test demonstrated that 3 out of 4 tines were engaged
with the ventricular myocardium. Acutely, the sensing was
12.6 mV, the impedance was 630 ohms, and the pacing
threshold was 0.5 V at 0.24 ms. After deployment of the second Micra AV, the Micra sheath was advanced to the distal
right ventricular outﬂow tract; however, the original Micra
AV had migrated to the left pulmonary artery and was

Figure 1 Initial angiogram demonstrating leadless pacemaker lodged in
interlobar branch of pulmonary artery with tine penetrating vessel wall (arrow) without extravasation of contrast.

beyond the reach of the Micra sheath. Several attempts
were made to retrieve the dislodged Micra AV via snare,
but these were not successful owing to a very distal position
of the device and difﬁculty in directing the snare to the vessel
of interest without proximal support. The decision was made
to abandon further attempts at retrieval at that time and
consider alternative options.
A computed tomography scan of the chest conﬁrmed that
the original Micra AV had embolized to the interlobar branch
of the left pulmonary artery. The patient began to experience
chest pain and there was concern for possible thrombus formation around the device. A repeat extraction attempt was
planned with the assistance of interventional radiology 2
days after the initial extraction attempt to accommodate the
complex scheduling needs of a coordinated effort.
The patient was placed under general anesthesia and intubated with a double-lumen endotracheal tube. A full cardiac
surgical team was on backup with a cardiac surgeon present
in the room during the procedure. Access to the right common femoral vein was obtained via ultrasound guidance
and use of a 5F Micro-Introducer kit (Vascular Solutions,
Minneapolis, MN), with subsequent placement of a 0.035"
guidewire (Cook, Bloomington, IN) followed by a 7F
vascular sheath (Cordis, Santa Clara, CA). The vein was
then preclosed using 2 Perclose devices (Abbott Vascular,
Santa Clara, CA). A 90-degree 6F Pigtail Soft-Vu catheter
(Angiodynamics, Queensbury, NY) was then used to navigate through the right atrium to the right ventricle and then
to the main pulmonary artery without dislodging the ventricular Micra AV. Once the Pigtail catheter was in place, a 260cm-length, 1 cm ﬂoppy Amplatz Super Stiff 0.035" guidewire (Boston Scientiﬁc, Marlborough, MA) was placed
through the catheter into a branch of the left pulmonary artery. The Pigtail catheter was subsequently removed and a
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Figure 2 A: Initial retrieval with single snare that was unsuccessful owing to persistent engagement of tines in vessel wall. The Amplatz Super Stiff wire (Boston Scientiﬁc, Marlborough, MA) is located in an adjacent interlobar branch of the pulmonary artery to help stabilize the sheath. B: Double-snare technique with
distal and proximal snare attachment. By cinching down the distal snare at the base of the tines, it retracts these tines from the vessel wall and enables distal control
of the device while the proximal snare is used to retract the device. Contrast injection demonstrates the tines are free from the vessel wall and there is no extravasation of contrast.

tapered dilator was used to dilate the common femoral vein
before a 24F Gore Dry-Seal sheath (Gore Medical, Flagstaff,
AZ) was placed over the wire to the inferior vena cava. Systemic anticoagulation with intravenous heparin was then
given via bolus. Next, a T24 Flowtriever sheath (Inari Medical, Irvine, CA) was placed over the wire into the left main
pulmonary artery. This sheath, which is traditionally used
to perform aspiration thrombectomy of pulmonary emboli,
has the appropriate length and ﬂexibility to reach the interlobar branch of the pulmonary artery and was conﬁrmed prior

to the case to have adequate diameter to retrieve the Micra
AV leadless pacemaker.
After the Amplatz guidewire was placed into an adjacent
branch of the pulmonary artery to maintain access, a contrast
injection under cine ﬂuoroscopy was performed to conﬁrm
the location of the device in relation to the pulmonary arterial
anatomy. It was noted that 1 of the device tines was in an
extravascular location; however, there was no extravasation
of contrast at baseline (Figure 1). A 20mm goose-neck 6F
snare (Medtronic PLC, Dublin, Ireland) was used in attempts

Figure 3 Manual atrial mechanical test post implant demonstrating post–ventricular atrial blanking (PAVB) period; A3 period, which corresponds to a sensed
atrial mechanical event (AM); and then ventricular pacing (VP) following the A4 period.
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to retrieve the Micra AV. With difﬁculty, the snare was successfully placed around the body of the pacemaker, but the
device could not be removed with gentle manual traction
applied to the body of the pacemaker, despite several attempts (Figure 2a). Since the distal tip of the device and tines
were lodged into the distal aspect of the interlobar branch, it
was not possible to grab the tines directly or turn the device.
The 20mm goose-neck snare was then advanced over the
body of the device and secured at the distal tip of the device at
the base of the tines. A second 20mm goose-neck snare was
then advanced via the T24 Flowtriever over the body of the
device and then slowly withdrawn while the snare was tightened to secure it at the proximal aspect of the Micra AV
(Figure 2b). The distal snare was then tightened further,
which retracted the tines from the wall of the vessel. Both
proximal and distal snares were then used together to retract
the device and pull it into the main body of the pulmonary artery. The Amplatz wire was withdrawn and then the Micra
AV could be pulled into the T24 Flowtriever sheath and
removed from the body. A repeat pulmonary angiogram
conﬁrmed that there was no extravasation of contrast outside
of the pulmonary vasculature. Protamine was given to reverse
anticoagulation in the event of microperforation of a pulmonary vessel that may have occurred. The sheath was removed
carefully under ﬂuoroscopy to prevent dislodgement of the
second Micra AV. The femoral vein was closed via securing
both Perclose sutures. Fluoroscopy conﬁrmed that the second
Micra AV was unchanged and a repeat device interrogation
showed stable parameters that were unchanged from the
beginning of the case. The patient was transferred to recovery
and discharged the following day. Post procedure, the patient’s chest pain resolved completely. At follow-up, device
interrogation conﬁrmed normal pacemaker function and his
chest and groin incision healed completely. His device interrogation demonstrated appropriate atrial mechanical sensing
and ventricular pacing (Figure 3). At follow-up visit, he made
a full recovery and his device check demonstrated he had a
total amount of ventricular pacing of 82% in an AS-VP pacing mode.

Discussion
There are several novel aspects of this case that merit discussion. Given the fact that this patient had recurrent surgical site
infections at different anatomic locations that were remote
from the time of implantation, the decision was made to pursue a leadless pacemaker, which avoids the presence of a subcutaneous device and also allows him the option of
atrioventricular synchrony. This is the ﬁrst reported demonstration of atrioventricular synchrony achieved with a leadless pacemaker in a pediatric patient. The Micra AV has a
projected battery longevity of 12 or more years at current programmed outputs, at which time a second Micra AV can be
placed or an alternate device will be considered.
It is noteworthy that despite having 3 out of 4 tines
engaged and having excellent sensing and pacing thresholds,
the original Micra AV leadless pacemaker still completely
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dislodged. This is extraordinarily unusual. The septal placement is the most common position for leadless pacemaker
placement, and the second Micra AV pacemaker was placed
slightly higher on the interventricular septum and has been
stable.
This is also the ﬁrst reported case of the T24 Flowtriever
sheath used to retrieve an embolized leadless pacemaker.
This sheath has greater length and greater ﬂexibility than
currently available cardiac sheaths and allowed the necessary
approximation to the location of the embolized device. The
use of a 2-snare technique was pivotal to the success of this
extraction, as it facilitated atraumatic retraction of the tines
from the vessel wall as well as enabled control of both proximal and distal ends of the device to safely and securely pull
the device into the sheath. An additional advantage of the T24
Flowtriever sheath was that it had the necessary luminal
diameter to remove the device internally and provide safe
passage out of the body and avoid having to drag the pacemaker with its exposed tines through the pulmonic valve,
right ventricle, and tricuspid valve. Finally, this case highlights the importance of a team-based approach to patient
care and through collaboration with interventional radiology,
cardiac anesthesiology, cardiac surgery, and pediatric electrophysiology it was possible to achieve a successful
outcome for this patient.
There have been other reports of retrieving leadless pacemakers via use of snares. There are reports of devices that dislodged, but remained within the heart, that were extracted
using 2 snares with either 1 or 2 deﬂectable sheaths.4–6
There are other case reports that describe embolization of a
leadless pacemaker to the pulmonary artery.7,8 However,
our case differs from each of these other reports by the
description of a single large sheath to retrieve a Micra from
a branch of a pulmonary artery using a 2-snare technique to
safely retract the distal tines and control both ends of the device.

Conclusion
For patients with recurrent surgical site infections, use of a
leadless pacemaker that allows for atrioventricular synchrony
is a feasible alternative, even in young patients. In the advent
of embolization of a leadless pacemaker to the pulmonary artery, use of a double-snare technique via a large, ﬂexible
sheath is an effective method to retrieve the device in a
safe manner.
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